Author:
Galea Jerome T.,Kinsler Janni J.,McLean Sarah,Calvo Gino,Sánchez Hugo,Leon Segundo R.,Brown Brandon
Funder
Merck Investigator-Initiated Studies Program of Merck & Co, Inc
National Institutes of Health
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,Social Psychology
Reference38 articles.
1. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.
2. McCormack S, Dunn D. Pragmatic open-label randomised trial of preexposure prophylaxis: the proud study [abstract 22LB]. Abstract presented at: Conference on Retroviruses and Opportunistic Infections (CROI); February 23–26, 2015; Seattle, Washington.
3. Grant RM, Anderson PL, McMahan VM, et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014;14(9):820–9.
4. Molina JM, Capitant C, Charreau I, Spire B et al. On demand PrEP With Oral TDF-FTC in MSM: results of the ANRS Ipergay trial [abstract 23LB]. Abstract presented at: Conference on Retroviruses and Opportunistic Infections (CROI); February 23–26, 2015; Seattle, Washington.
5. Krakower DS, Mayer KH. Pre-exposure prophylaxis to prevent HIV infection: current status, future opportunities and challenges. Drugs. 2015;75(3):243–51.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献